"The market is not liking Bristol-Myers Squibb" in pre-market trading, says @DavidWestin. Here's the latest on the mega deal that unites two cancer-drug makers https://t.co/RK2a302Cr7 pic.twitter.com/aNzZjvWLqL
— Bloomberg (@business) January 3, 2019
Source: Twitter
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.